New York State's landmark policies on oversight and compensation for egg donation to stem cell research

In 2009, New York became the first US state to implement a policy permitting researchers to use public funds to reimburse women who donate oocytes directly and solely to stem cell research, not only for the woman's out-of-pocket expenses, but also for the time, burden and discomfort associated...

Full description

Saved in:
Bibliographic Details
Published inRegenerative medicine Vol. 7; no. 3; p. 397
Main Author Roxland, Beth E
Format Journal Article
LanguageEnglish
Published England Future Medicine Ltd 01.05.2012
Subjects
Online AccessGet full text
ISSN1746-0751
1746-076X
1746-076X
DOI10.2217/rme.12.20

Cover

More Information
Summary:In 2009, New York became the first US state to implement a policy permitting researchers to use public funds to reimburse women who donate oocytes directly and solely to stem cell research, not only for the woman's out-of-pocket expenses, but also for the time, burden and discomfort associated with the donation process. The debate about the propriety of such compensation was recently renewed with the publication of a stem cell study in which women were provided with compensation for donating their eggs. This article explores the scientific and ethical rationales that led to New York's decision to allow donor compensation. The multifaceted deliberation process and comprehensive policies may serve as a model for other states and countries considering the issue of oocyte donor compensation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:1746-0751
1746-076X
1746-076X
DOI:10.2217/rme.12.20